177 related articles for article (PubMed ID: 26507391)
1. Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study.
Papadimitriou DT; Dermitzaki E; Papagianni M; Papaioannou G; Papaevangelou V; Papadimitriou A
J Endocrinol Invest; 2016 Apr; 39(4):439-46. PubMed ID: 26507391
[TBL] [Abstract][Full Text] [Related]
2. Anastrozole monotherapy further improves near-adult height after the initial combined treatment with leuprorelin and anastrozole in early-maturing girls with compromised growth prediction: results from the second phase of the GAIL study.
Papadimitriou DT; Dermitzaki E; Christopoulos P; Livadas S; Grivea IN; Mastorakos G
Front Endocrinol (Lausanne); 2024; 15():1366970. PubMed ID: 38628587
[TBL] [Abstract][Full Text] [Related]
3. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
Neely EK; Kumar RB; Payne SL; Ranadive SA; Suchet DI
J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
[TBL] [Abstract][Full Text] [Related]
4. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
5. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB
J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
Hero M; Norjavaara E; Dunkel L
J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
[TBL] [Abstract][Full Text] [Related]
7. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
Mauras N; Gonzalez de Pijem L; Hsiang HY; Desrosiers P; Rapaport R; Schwartz ID; Klein KO; Singh RJ; Miyamoto A; Bishop K
J Clin Endocrinol Metab; 2008 Mar; 93(3):823-31. PubMed ID: 18165285
[TBL] [Abstract][Full Text] [Related]
8. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
Mieszczak J; Lowe ES; Plourde P; Eugster EA
J Clin Endocrinol Metab; 2008 Jul; 93(7):2751-4. PubMed ID: 18397987
[TBL] [Abstract][Full Text] [Related]
9. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review.
Shams K; Cameo T; Fennoy I; Hassoun AA; Lerner SE; Aranoff GS; Sopher AB; Yang C; McMahon DJ; Oberfield SE
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):725-30. PubMed ID: 24756052
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment with GH and anastrozole in a pubertal boy with Cushing's disease and postsurgical GH deficiency.
Boronat M; Marrero D; López-Plasencia Y; Nóvoa Y; García-Delgado Y; Nóvoa FJ
Eur J Endocrinol; 2012 Jun; 166(6):1101-5. PubMed ID: 22447814
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
[TBL] [Abstract][Full Text] [Related]
12. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
[TBL] [Abstract][Full Text] [Related]
13. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
14. Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome.
Alves C; Silva SF
J Pediatr Endocrinol Metab; 2012; 25(3-4):323-5. PubMed ID: 22774233
[TBL] [Abstract][Full Text] [Related]
15. Are aromatase inhibitors in boys with predicted short stature and/or rapidly advancing bone age effective and safe?
Ferris JA; Geffner ME
J Pediatr Endocrinol Metab; 2017 Mar; 30(3):311-317. PubMed ID: 28207416
[TBL] [Abstract][Full Text] [Related]
16. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue.
Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Katsumata N; Tachibana K; Nose O; Hibi I
Acta Paediatr Suppl; 1999 Feb; 88(428):85-8. PubMed ID: 10102060
[TBL] [Abstract][Full Text] [Related]
17. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
Massart F; Federico G; Harrell JC; Saggese G
Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
[TBL] [Abstract][Full Text] [Related]
18. Use of aromatase inhibitors in children and adolescents: what's new?
Diaz-Thomas A; Shulman D
Curr Opin Pediatr; 2010 Aug; 22(4):501-7. PubMed ID: 20489637
[TBL] [Abstract][Full Text] [Related]
19. Should Skeletal Maturation Be Manipulated for Extra Height Gain?
Wit JM
Front Endocrinol (Lausanne); 2021; 12():812196. PubMed ID: 34975773
[TBL] [Abstract][Full Text] [Related]
20. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.
Yanovski JA; Rose SR; Municchi G; Pescovitz OH; Hill SC; Cassorla FG; Cutler GB
N Engl J Med; 2003 Mar; 348(10):908-17. PubMed ID: 12621135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
